Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it received a Complete Response Letter (CRL) from the U.S. Food a…
Author: Eyewire Today
Revised Glaucoma Guidance is Published
The Joint Group on NICE Glaucoma Guideline has published revised guidance clarifying the criteria for the referral of suspected glaucoma patients. Issued jointly by the College of Optometrists and the Royal College of Ophthalmologists, the updated ad…
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in CRVO and in Phase 2 Study in DME
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic solution) in the COPERNICUS study, which is led by Regeneron, the first of two Phase 3 studies in patients with m…
Lpath Grants Pfizer Exclusive Option for Worldwide License for AMD Treatment iSONEP
Lpath, Inc. has entered into an agreement providing Pfizer with an exclusive option for a worldwide license to develop and commercialize iSONEP Lpath’s lead monoclonal antibody product candidate, which is being evaluated for the treatment of wet age-…
AAO Joins Forces with Cloud Nine Development, LLC on the Eye Handbook iPhone Application
The American Academy of Ophthalmology (Academy) has collaborated with Cloud Nine Development, LLC, to enhance its free iPhone application, the Eye Handbook. The application, created for ophthalmologists by ophthalmologists, offers ophthalmic calculat…
Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook Report Available
Research and Markets has announced the addition of GlobalData’s new report “Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook” to their offering. Our report, Premium Intraocular Lenses (IOLs) Market: Trends and Future Outlook provid…
Mimetogen Pharmaceuticals Announces Initiation Of Phase II Clinical Trial Of Novel NGF Mimetic In Patients With Dry Eye
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D…
B+L’s Biotrue Named a Top Innovation of the Year
Bausch + Lomb Inc.s Biotrue contact lens solution is one of the 100 best innovations of the year, according to Popular Science. The publication cited Biotrues matching of a human tears PH level and thus the fact it doesnt cause stinging.
Eye Allergies Often Overlooked, Undertreated
Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov. 11-16. Full Story →
Online Kid’s Cataract Calculator Launched
Lens manufacturer Transitions Optical has launched a new online tool which predicts the probability of a child developing cataracts later in life. The Childrens Cataract Calculator aims to help practitioners educate parents about the importance of ch…
Novartis could stick with 77 percent stake in Alcon
Swiss drugmaker Novartis AG has not ruled out sticking with its 77 percent stake in US-listed eyecare group Alcon, Novartis chief executive Joe Jimenez was quoted as saying on Tuesday. “The intention is to have 100 per cent. But Nestle owned 77 per c…
Bausch + Lomb Initiates Phase 2b Study With Glaucoma Drug Candidate
NicOx S.A. today announced that its partner Bausch + Lomb has initiated a phase 2b clinical study with BOL-303259-X, previously known as NCX 116. BOL-303259-X is a nitric oxide-donating prostaglandin F2-alpha analog, which lowers intraocular pressure…
Santen Inc. Appoints Associate Director of Strategic Marketing
Santen Inc., a wholly owned subsidiary of Santen Pharmaceuticals, has announced the appointment of Yuan Chang as the Associate Director of Strategic Marketing. Full Story →
AMA to Docs: Be Careful About What You Post Online
The American Medical Association has adopted a series of recommendations to help physicians keep their online presence appropriate and professional. Full Story →
ICMR to Begin Research in the Area of Congenital Blindness Soon
As a special initiative to promote research in the area of congenital blindness, the Indian Council of Medical Research (ICMR) will soon begin research in the area of ophthalmology. The main objective of the study is primarily to investigate causes o…
Ophthalmic Imaging Systems Reports Third Quarter Financial Results
Ophthalmic Imaging Systems, a leading digital imaging, image management, Electronic Medical Records (EMR) and Practice Management (PM) company, today reported financial results for the three and nine months ended September 30, 2010, and provided an u…
Carl Zeiss Meditec Receives FDA Clearance for the IOLMaster 500 Biometer
Carl Zeiss Meditec today announced that the IOLMaster 500, the newest biometer used to calculate all necessary eye measurements for optimal lens selection for cataract surgery procedures, has received marketing clearance from the U.S. Food and Drug A…
OCT Device Added to Diabetes Screening List
Topcon has gained approval for its 3D OCT-2000 to be added to the list of devices approved by the English National Screening Programme for Diabetic Screening (ENSPDR). The device is Topcon’s latest camera integrating a Spectral Domain OCT, which anal…
Allergan Plans To Train Doctors, Sell Insurers on Botox for Migraines
Irvine, CA-drug maker Allergan Inc. has built itself into a multibillion dollar company by going after, and even creating, new markets. Now its looking to do that with flagship drug Botox as a treatment for chronic migraine head-aches. The Food and D…
IRIDEX Reports Improved Third Quarter 2010 Financial Results
IRIDEX Corporation today reported financial results for the third quarter ended October 2, 2010. Earnings of $0.9 million or $0.09 per diluted share, up from $0.6 million or $0.07 per diluted share reported in the third quarter 2009. Total sales incr…